Herbal Hepatotoxicity: Clinical characteristics and listing compilation

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  Frenzel, Christian ^a   Teschke, Rolf ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Hepatotoxicity; Herb induced liver injury (HILI); Herbal drug; Herbal hepatotoxicity

Indexed keywords

BIOLOGICAL MARKER; HERBACEOUS AGENT; PLANT MEDICINAL PRODUCT;

CHEMISTRY; CHINESE MEDICINE; DRUG CONTAMINATION; FACTUAL DATABASE; HUMAN; METABOLISM; PATHOLOGY; STANDARDS; TOXIC HEPATITIS;

BIOMARKERS; CHEMICAL AND DRUG INDUCED LIVER INJURY; DATABASES, FACTUAL; DRUG CONTAMINATION; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; PLANT PREPARATIONS;

EID: 84967044760     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050588     Document Type: Review

References (317)

1. Tu, Y.; Ni, M.Y.; Zhong, Y.R.; Li, L.N.; Cui, S.L.; Zhang, M.Q.; Qang, W.Z.; Hi, Z.; Li, X.T. Studies on the constituents of Artemisia annua Part II. Planta Medica 1982, 44, 143-145.
2. Tu, Y. The development of new antimalarial drugs: Qinghaosu and dihydro-qinghaosu. Chin. Med. J. 1999, 112, 976-977.
3. Efferth, T.; Romero, M.R.; Wolf, D.G.; Stamminger, T.; Marin, J.J.G.; Marschall, M. The antiviral activities of artemisinin and artesunate. Clin. Infect. Dis. 2008, 47, 804-808
4. Maridass, M.; de Britto, A.J. Origin of plant derived medicines. Ethnobot Leaflets 2008, 12, 373-387.
5. Pelkonen, O.; Xu, O.; Fan, T.P. Why is research on herbal medicinal products important and how can we improve quality? J. Tradit. Complement. Med. 2014, 4, 1-7
6. Ekor, M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014, 4, 1-10
7. Teschke, R.; Wolff, A.; Frenzel, C.; Eickhoff, A.; Schulze, J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J. Gastroenterol. 2015, 21, 4466-4490
8. Teschke, R.; Eickhoff, A. Herbal hepatotoxicity in traditional and modern medicine: Actual key issues and new encouraging steps. Front. Pharmacol. 2015, 6, 72
9. Calitz, C.; du Plessis, L.; Gouws, C.; Steyn, D.; Steenekamp, J.; Muller, C.; Hamman, S. Herbal hepatotoxicity: Current status, examples, and challenges. Expert Opin. Drug Metab. Toxicol. 2015, 11, 1551-1565
10. Zhao, P.; Wang, C.; Liu, W.; Chen, G.; Liu, X.; Wang, X.; Wang, B.; Yu, L.; Sun, Y.; Liang, X.; et al. Causes and outcomes of acute liver failure in China. PLoS ONE 2013, 8, e80991
11. Avigan, M.I.; Mozersky, R.P.; Seeff, L.B. Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. Int. J. Mol. Sci. 2016, 17, 331
12. Danan, G.; Teschke, R. RUCAM in drug and herb induced liver injury: The update. Int. J. Mol. Sci. 2016, 17, 14
13. Teschke, R.; Zhang, L.; Melzer, L.; Schulze, J.; Eickhoff, A. Green tea extract and the risk of drug-induced liver injury. Expert Opin. Drug Metab. Toxicol. 2014, 10, 1663-1676
14. Zhang, L.; Yan, J.; Liu, X.; Ye, Z.; Yang, X.; Meyboom, R.; Chan, K.; Shaw, D.; Duez, P. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective. J. Ethnopharmacol. 2012, 140, 519-525.
15. Teschke, R.; Schwarzenboeck, A.; Eickhoff, A.; Frenzel, C.; Wolff, A.; Schulze, J. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin. Drug Saf. 2013, 12, 339-366
16. Health Products and Food Branch Marketed Health Products Directorate Canadian Adverse Reaction Newsletter Editorial Team. Available online: http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v20n1-eng.php#a1t1 (accessed on 15 March 2016).
17. Ko, R.J. Adulterants in Asian patent medicines. N. Engl. J. Med. 1998, 339, 847
18. Huang, W.F.; Wen, K.C.; Hsiao, M.L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J. Clin. Pharmacol. 1997, 37, 344-350
19. Espinoza, E.O.; Mann, M.J.; Bleasdell, B. Arsenic and mercury in traditional Chinese herbal balls. N. Engl. J. Med. 1995, 333, 803-804
20. Gertner, E.; Marshall, P.S.; Filandrinos, D.; Potek, A.S.; Smith, T.M. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis. Rheum. 1995, 38, 614-617
21. Kang-Yum, E.; Oransky, S.H. Chinese patent medicine as a potential source of mercury poisoning. Vet. Hum. Toxicol. 1992, 34, 235-238
22. Navarro, V.J.; Bonkovsky, H.L.; Hwang, S.I.; Vega, M.; Barnhart, H.; Serrano, J. Catechins in dietary supplements and hepatotoxicity. Dig. Dis. Sci. 2013, 58, 2682-2690
23. Mazzanti, G.; Menniti-Ippolito, F.; Moro, P.A.; Cassetti, F.; Raschetti, R.; Santuccio, C.; Mastrangelo, S. Hepatotoxicity from green tea: A review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol. 2009, 65, 331-341
24. Sarma, D.N.; Barrett, M.L.; Chavez, M.L.; Gardiner, P.; Ko, R.; Mahady, G.B.; Marles, R.J.; Pellicore, L.S.; Giancaspro, G.I.; Low Dog, T. Safety of green tea extract: A systematic review by the US Pharmacopeia. Drug Saf. 2008, 31, 469-484
25. Wu, G.L.; Yu, G.Y.; Chen, J. Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon. Zhongguo Zhong Yao Za Zhi 2008, 33, 2402-2404. (In Chinese)
26. Lin, G.; Wang, J.Y.; Li, N.; Li, M.; Gao, H.; Ji, Y.; Zhang, F.; Wang, H.; Zhou, Y.; Ye, Y.; et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J. Hepatol. 2011, 54, 666-673
27. Gao, X.S.; Xiao, S.S.; He, J.F. Analysis of alkaloids in Sedum aizoon and establishment of hepatic veno-occlusive model in mice. Chin. J. Integr. Trad. Western Med. Dig. 2006, 14, 311-313.
28. Gao, H.; Li, N.; Wang, J.Y.; Zhang, S.C.; Lin, G. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J. Dig. Dis. 2012, 13, 33-39
29. Wang, J.Y.; Gao, H. Tusanqi and hepatic sinusoidal obstruction syndrome. J. Dig. Dis. 2014, 15, 105-107
30. Teschke, R.; Wolff, A.; Frenzel, C.; Schulze, J.; Eickhoff, A. Herbal hepatotoxicity: A tabular compilation of reported cases. Liver Int. 2012, 32, 1543-1556
31. Dai, H.F.; Gao, Y.; Yang, M.; Yu, C.H.; Gu, Z.Y.; Chen, W.X. Hepatic veno-occlusive disease induced by Gynura segetum: Report of two cases. Hepatobiliary Pancreat. Dis. Int. 2006, 5, 406-408
32. Kumana, C.R.; Ng, M.; Lin, H.J.; Ko, W.; Wu, P.C.; Todd, D. Hepatic veno-occlusive disease due to toxic alkaloid in herbal tea. Lancet 1983, 322, 1360-1361
33. Kumana, C.R.; Ng, M.; Lin, H.J.; Ko, W.; Wu, P.C.; Todd, D. Herbal tea induced hepatic veno-occlusive disease: Quantification of toxic alkaloid exposure in adults. Gut 1985, 26, 101-104
34. Culvenor, C.C.J.; Edgar, J.A.; Smith, L.W.; Kumana, C.R.; Lin, H.J. Heliotropium lasiocarpum Fisch and Mey identified as cause of veno-occlusive disease due to herbal tea. Lancet 1986, 1, 978
35. Ernst, E. Heavy metals in traditional Indian remedies. Eur. J. Clin. Pharmacol. 2002, 57, 891-896
36. Ernst, E. Review article. Methodological aspects of Traditional Chinese Medicine (TCM). Ann. Acad. Med. Singap. 2006, 35, 773-774
37. Saper, R.B.; Phillips, R.S.; Sehgal, A.; Khouri, N.; Davis, R.B.; Paquin, J.; Thuppil, V.; Kalses, S.N. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the internet. JAMA 2008, 300, 915-923
38. Bunchorntavakul, C.; Reddy, K.R. Review article: Herbal and dietary supplement hepatotoxicity. Aliment Pharmacol. Ther. 2013, 37, 3-17
39. Dantuluri, S.; North-Lewis, P.; Karthik, S.V. Gotu Kola induced hepatotoxicity in a child-Need for causation with alternative remedies. Dig. Liver Dis. 2011, 43, 500
40. Jorge, O.A.; Jorge, A.D. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev. Esp. Enferm. Dig. 2005, 97, 115-124
41. Teschke, R.; Bahre, R. Severe hepatotoxicity by Indian Ayurvedic herbal products, A structured causality assessment. Ann. Hepatol. 2009, 8, 258-266
42. Fleig, W.W.; Morgan, M.Y.; Holzer, M.A. European multicenter study group. The ayurvedic drug Liv.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double blind, placebo-controlled clinical trial. J. Hepatol. 1997, 126, 127
43. Adachi, M.; Saito, H.; Kobayashi, H.; Horie, Y.; Kato, S.; Yoshioka, M.; Ishii, H. Hepatic injury in 12 patients taking the herbal loss aids Chaso and Onshido. Ann. Intern. Med. 2003, 139, 488-492
44. Lau, G.; Lo, D.S.; Yao, Y.J.; Leong, H.T.; Chan, C.L.; Chu, S.S. A fatal case of hepatic failure possibly induced by nitrosofenfluramine: A case report. Med. Sci. Law 2004, 44, 252-263
45. Kanda, T.; Yokosuka, O.; Okada, O.; Suzuki, Y.; Saisho, H. Severe hepatotoxicity associated with Chinese diet product “Ohnshidou-Genbi-Kounou”. J. Gastroenterol. Hepatol. 2003, 18, 354-355
46. Kanda, T.; Yokosuka, O.; Tada, M.; Kurihara, T.; Yoshida, S.; Suzuki, Y.; Nagao, K.; Saisho, H. N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis. J. Gastroenterol. Hepatol. 2003, 18, 999-1000
47. Teschke, R. Traditional Chinese Medicine induced liver injury. J. Clin. Translat. Hepatol. 2014, 2, 80-94
48. Teschke, R.; Schulze, J.; Eickhoff, A.; Wolff, A.; Frenzel, C. Review Article: Mysterious Hawaii liver disease Case-Naproxen overdose as cause rather than OxyELITE Pro? J. Liver Clin. Res. 2015, 2, 1013.
49. Teschke, R.; Schwarzenboeck, A.; Frenzel, C.; Schulze, J.; Eickhoff, A.; Wolff, A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann. Hepatol. 2016, 15, 91-119
50. Teschke, R.; Eickhoff, A. The Honolulu Liver disease cluster at the Medical Center: Its mysteries and challenges. Int. J. Mol. Sci. 2016, 17, 476
51. Ernst, E. Adulteration of Chinese herbal medicines with synthetic drugs: A systematic review. J. Int. Med. 2002, 252, 107-113
52. Efferth, T.; Kaina, B. Toxicities by herbal medicines with emphasis to Traditional Chinese medicine. Curr. Drug Metab. 2011, 12, 989-996
53. Shaw, D. Toxicological risks of Chinese herbs. Planta Med. 2010, 76, 2012-2018
54. Teschke, R.; Qiu, S.X.; Xuan, T.D.; Lebot, V. Kava and kava hepatotoxicity: Requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother. Res. 2011, 25, 1262-1274
55. Rowe, A.; Ramzan, I. Letter to the Editor: Are mould hepatotoxins responsible for kava hepatotoxicity? Phytother. Res. 2012, 26, 1768-1770
56. Teschke, R.; Sarris, J.; Lebot, V. Contaminant hepatotoxins as culprits for kava hepatotoxicity-Fact or fiction? Phytother. Res. 2013, 27, 472-474
57. Teschke, R.; Qiu, S.X.; Lebot, V. Herbal hepatotoxicity by kava: Update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig. Liver Dis. 2011, 43, 676-681
58. Lebot, V. The quality of kava consumed in the South Pacific. HerbalGram 2006, 71, 34-37.
59. Schmidt, M. Quality criteria for kava. HerbalGram 2007, 73, 45-49.
60. Teschke, R.; Lebot, V. Proposal for a Kava Quality Standardization Code. Food Chem. Toxicol. 2011, 49, 2503-2516
61. Sarris, J.; Adams, J.; Wardle, J.L. Editorial: Time for a reassessment of the use of kava in anxiety? Complement. Ther. Med. 2009, 17, 121-122
62. Sarris, J.; Teschke, R.; Stough, C.; Scholey, A.; Schweitzer, I. Re-introduction of kava (Piper methysticum) to the EU: Is there a way forward? Planta Med. 2011, 77, 107-110
63. Sarris, J.; Kavanagh, D.J. Kava and St. John’s wort: Current evidence for use in mood and anxiety disorders. J. Altern. Complement. Med. 2009, 15, 827-836
64. Sarris, J.; Kavanagh, D.J.; Byrne, G.; Bone, K.M.; Adams, J.; Deed, G. The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology 2009, 205, 399-407
65. Sarris, J.; Adams, J.; Kavanagh, D. An explorative qualitative analysis of participants’ experience of using kava versus placebo in an RCT. Aust. J. Med. Herbalism. 2010, 22, 12-16.
66. Sarris, J.; LaPorte, E.; Schweitzer, I. Kava: A comprehensive review of efficacy, safety, and psychopharmacology. Aust. N. Z. J. Psychiatry 2011, 45, 36-44
67. Sarris, J.; Panossian, A.; Schweitzer, I.; Stough, C.; Scholey, A. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur. Neuropsychopharmacol. 2011, 21, 841-860
68. Sarris, J.; Stough, C.; Bousman, C.A.; Wahid, T.; Murray, G.; Teschke, R.; Savage, K.M.; Dowell, A.; Ng, C.; Schweitzer, I. Kava in the treatment of generalized anxiety disorder: A double-blind, randomized, placebo-controlled study. J. Clin. Psychiatry 2013, 33, 643-648
69. Savage, K.M.; Stough, C.K.; Byrne, G.J.; Scholey, A.; Bousman, C.; Murphy, J.; Macdonald, P.; Suo, C.; Hughes, M.; Thomas, S.; et al. Kava for the Treatment of Generalised Anxiety Disorder (K-GAD): Study protocol for a randomized controlled trial. Trials 2015, 16, 493
70. Ma, X.; Peng, J.H.; Hu, Y.Y. Chinese herbal medicine-induced liver injury. J. Clin. Transl. Hepatol. 2014, 2, 170-175
71. Larrey, D.; Faure, S. Herbal medicine hepatotoxicity: A new step with development of specific biomarkers. J. Hepatol. 2011, 54, 599-601
72. Larrey, D.; Vial, T.; Pauwels, A.; Castot, A.; Biour, M.; David, M.; Michel, H. Hepatitis after germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann. Intern. Med. 1992, 117, 129-132
73. Urban, T.J.; Daly, A.K.; Aithal, G.P. Genetic basis of drug-induced liver injury: Present and future. Semin. Liver Dis. 2014, 34, 123-133
74. Andrade, R.J.; Robles, M.; Ulzurrun, E.; Lucena, M.I. Drug-induced liver injury: Insights from genetic studies. Pharmacogenomics 2009, 10, 1467-187
75. Chen, M.; Borlak, J.; Tong, W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology 2013, 58, 388-396
76. Lammert, C.; Einarsson, S.; Saha, C.; Niklasson, A.; Bjornsson, E.; Chalasani, N. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals. Hepatology 2008, 47, 2003-2009
77. Zimmerman, H.J. Hepatotoxicity; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 1999.
78. Teschke, R.; Frenzel, C.; Glass, X.; Schulze, J.; Eickhoff, A. Greater Celandine hepatotoxicity: A clinical review. Ann. Hepatol. 2012, 11, 838-848
79. Teschke, R.; Glass, X.; Schulze, J.; Eickhoff, A. Suspected Greater Celandine hepatotoxicity: Liver specific causality evaluation of published case reports from Europe. Eur. J. Gastroenterol. Hepatol. 2012, 24, 270-280
80. Teschke, R. Kava hepatotoxicity: A clinical review. Ann. Hepatol. 2010, 9, 251-265
81. Teschke, R.; Schwarzenboeck, A.; Hennermann, K.H. Kava hepatotoxicity: A clinical survey and critical analysis of 26 suspected cases. Eur. J. Gastroenterol. Hepatol. 2008, 20, 1182-1193
82. Teschke, R.; Gaus, W.; Loew, D. Kava extracts: Safety and risks including rare hepatotoxicity. Phytomedicine 2003, 10, 440-446
83. Teschke, R.; Schwarzenboeck, A.; Akinci, A. Kava hepatotoxicity: A European view. N. Z. Med. J. 2008, 121, 90-98
84. Teschke, R.; Wolff, A. Kava hepatotoxicity: Regulatory data selection and causality assessment. Dig. Liver Dis. 2009, 41, 891-901
85. Teschke, R.; Schulze, J. Risk of kava hepatotoxicity and the FDA consumer advisory. J. Am. Med. Assoc. 2010, 304, 2174-2175
86. Teschke, R. Kava hepatotoxicity: Pathogenetic aspects and prospective considerations. Liver Int. 2010, 30, 1270-1279
87. Teschke, R. Special report. Kava and the risk of liver toxicity: Past, current, and future. Am. Herb. Prod. Assoc. 2011, 26, 1-17.
88. Teschke, R.; Wolff, A. Regulatory causality evaluation methods applied in kava hepatotoxicity: Are they appropriate? Regul. Toxicol. Pharmacol. 2011, 59, 1-7
89. Olsen, L.R.; Grillo, M.P.; Skonberg, C. Constituents in kava extracts potentially involved in hepatotoxicity: A review. Chem. Res. Toxicol. 2011, 24, 992-1002
90. Martin, A.C.; Johnston, E.; Xing, C.; Hegeman, A.D. Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster). PLoS ONE 2014, 9, e111572
91. Schmidt, M. German court ruling reverses kava ban; German regulatory authority appeals decision. HerbalGram 2014, 103, 38-42.
92. Kuchta, K.; Schmidt, M.; Nahrstedt, A. German kava ban lifted by court: The alleged hepatotoxicity of kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med. 2015, 81, 1647-1653
93. Verwaltungsgericht Köln, 7 K 2197/12. Available online: http://www.justiz.nrw.de/nrwe/ovgs/vg_koeln/j2014/7_K_2197_12_Urteil_20140520.html (accessed on 15 March 2016).
94. BfArM. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany. Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. 14 June 2002. Available online: http://www.spc.int/cis/documents/02_0714_BfArM_Kava_Removal.pdf (accessed on 15 March 2016).
95. Fu, P.P.; Xia, Q.; Lin, G.; Chou, M.W. Pyrrolizidine alkaloids-Genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab. Rev. 2004, 36, 1-55
96. Roulet, M.; Laurini, R.; Rivier, L.; Calame, A. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J. Pediatr. 1988, 112, 433-436
97. Lee, C.H.; Wang, J.D.; Chen, P.C. Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639,779 patients with hepatitis B virus infection. PLoS ONE 2011, 6, e16064
98. Liu, Y.; Li, Z.; Liu, X.; Pan, R. Review on the toxic effects of radix Bupleuri. Curr. Opin. Complement. Altern. Med. 2014, 1, 3-7.
99. Lei, X.; Chen, J.; Ren, J.; Li, Y.; Zhai, J.; Mu, W.; Zhang, L.; Zheng, W.; Tian, G.; Shang, H. Liver damage associated with Polygonum multiflorum Thunb.: A systematic review of case reports and case series. Evid. Based Complement. Altern. Med. 2015, 4597949
100. Mazzanti, G.; di Soto, A.; Vitalone, A. Hepatotoxicity of green tea: An update. Arch. Toxicol. 2015, 89, 1175-1191
101. Chau, T.N.; Cheung, W.I.; Ngan, T.; Lin, J.; Lee, K.W.S.; Poon, W.T.; Leung, V.K.S.; Mak, T.; Tse, M.L.; the Hong Kong Herb-Induced Liver Injury Network (HK-HILIN). Causality assessment of herb-induced liver injury using multidisciplinary approach and the Roussel Uclaf Causality assessment Method (RUCAM). Clin. Toxicol. 2011, 49, 34-39
102. Zhou, Y.; Qin, S.; Wang, K. Biomarkers of drug-induced liver injury. Curr. Biomark. Find 2013, 3, 1-9.
103. Yang, X.; Salminen, W.F.; Schnackenberg, L.K. Current and emerging biomarkers of hepatotoxicity. Curr. Biomark. Find 2012, 2, 43-55.
104. Chalasani, N.; Björnsson, E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010, 138, 2246-2259
105. Mahady, G.B.; Low Dog, T.; Barrett, M.L.; Chavez, M.L.; Gardiner, P.; Ko, R.; Marles, R.J.; Pellicore, L.S.; Giancaspro, G.I.; Sarma, D.N. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008, 15, 628-638
106. Teschke, R.; Bahre, R.; Genthner, A.; Fuchs, J.; Schmidt-Taenzer, W.; Wolff, A. Suspected black cohosh Hepatotoxicity-Challenges and pitfalls of causality assessment. Maturitas 2009, 63, 302-314
107. Teschke, R. Black cohosh and suspected hepatotoxicity-Inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: A critical review. Menopause 2010, 17, 426-440
108. Teschke, R.; Schulze, J. Suspected herbal hepatotoxicity: Requirements for appropriate causality assessment by the US Pharmacopeia. Drug Saf. 2012, 12, 1091-1097
109. Teschke, R.; Schmidt-Taenzer, W.; Wolff, A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: Is the liver unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol. Drug Saf. 2011, 20, 567-582
110. Teschke, R.; Schwarzenboeck, A.; Schmidt-Taenzer, W.; Wolff, A.; Hennermann, K.H. Herb induced liver injury presumably caused by black cohosh: A survey of initially purported cases and herbal quality specifications. Ann. Hepatol. 2011, 11, 249-259.
111. Liss, G.; Lewis, J.H. Drug-induced liver injury: What was new in 2008? Expert Opin. Drug Metab. Toxicol. 2009, 5, 843-860
112. World Health Organization. Assessments of the Risk of Hepatotoxicity with Kava Products; WHO Document Production Services: Geneva, Switzerland, 2007.
113. BfArM, Bundesinstitut für Arzneimittel und Medizinprodukte (German regulatory agency). Bekanntmachung. Abwehr von Gefahren durch Arzneimittel, Stufe II, Anhörung: Schöllkraut-haltige Arzneimittel zur innerlichen Anwendung. 6 May 2005. Available online: http://www.bfarm.de/cae/servlet/contentblob/1014620/publicationFile/66198/schoellkraut-anhoerung_050505.pdf (accessed on 15 March 2016).
114. Schmidt, M.; Morgan, M.; Bone, K.; McMillan, J. Kava: A risk-benefit assessment. In The Essential Guide to Herbal Safety; Mills, M., Bone, K., Eds.; Elsevier Churchill Livingstone: St. Louis, MS, USA, 2005; pp. 155-221.
115. DCGMA, Drug Commission of the German Medical Association (Arzneimittelkommission der Deutschen Ärzteschaft). Hepatitis in connection with Umckaloabo®. Deutsches Ärzteblatt 2011, 108, C1399-C1400. (In German)
116. Teschke, R.; Frenzel, C.; Schulze, J.; Eickhoff, A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul. Toxicol. Pharmacol. 2012, 63, 1-9
117. Teschke, R.; Frenzel, C.; Schulze, J.; Eickhoff, A. Suspected herbal hepatotoxicity: The pharmacovigilance dilemma with disputed and obsolete evaluation methods. Regul. Toxicol. Pharmacol. 2012, 64, 343-344
118. Teschke, R.; Frenzel, C.; Wolff, A.; Herzog, J.; Glass, X.; Schulze, J.; Eickhoff, A. Initially purported hepatotoxicity by Pelargonium sidoides: The dilemma of pharmacovigilance and proposals for improvements. Ann. Hepatol. 2012, 11, 500-512
119. Teschke, R.; Frenzel, C.; Schulze, J.; Schwarzenboeck, A.; Eickhoff, A. Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J. Hepatol. 2013, 5, 353-363
120. Melchart, D.; Linde, K.; Weidenhammer, W.; Hager, S.; Shaw, D.; Bauer, R. Liver enzyme elevations in patients treated with traditional Chinese medicine. JAMA 1999, 282, 28-29
121. Au, J.S.; Navarro, V.J.; Rossi, S. Review article: Drug induced liver injury-Its pathophysiology and evolving diagnostic tools. Aliment. Pharmacol. Ther. 2011, 34, 11-20
122. Dalton, H.R.; Fellows, H.J.; Stableforth, W.; Joseph, M.; Thurairajah, P.H.; Warshow, U.; Hazeldine, S.; Remnarace, R.; Ijaz, S.; Hussaini, S.H.; et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment. Pharmacol. Ther. 2007, 26, 1429-1435
123. Davern, T.J.; Chalasani, N.; Fontana, R.J.; Hayashi, P.H.; Protiva, P.; Kleiner, D.E.; Engle, R.E.; Nguyen, H.; Emerson, S.U.; Purcell, R.H.; et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011, 141, 1665-1672
124. Hoofnagle, J.H.; Nelson, K.E.; Purcell, R.H. Review article: Hepatitis E. N. Engl. J. Med. 2012, 367, 1237-1244
125. Teschke, R.; Andrade, R. Editorial. Drug-induced liver injury: Expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment. Gastroenterology 2015, 148, 1271-1273
126. Chen, E.Y.; Baum, K.; Collins, W.; Löve, A.; Merz, M.; Olafsson, S.; Björnsson, E.S.; Lee, W.M. Hepatitis E masquerading as drug-induced liver injury. Hepatology 2012, 56, 2420-2423
127. Bénichou, C.; Danan, G.; Flahault, A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J. Clin. Epidemiol. 1993, 46, 1331-1336
128. Teschke, R.; Zhang, L.; Long, H.; Schwarzenboeck, A.; Schmidt-Taenzer, W.; Genthner, A.; Wolff, A.; Frenzel, C.; Schulze, J.; Eickhoff, A. Traditional Chinese Medicine and herbal hepatotoxicity: A tabular compilation of reported cases. Ann. Hepatol. 2015, 14, 7-19
129. Teschke, R.; Genthner, A.; Wolff, A.; Frenzel, C.; Schulze, J.; Eickhoff, A. Herbal hepatotoxicity: Analysis of cases with initially reported positive reexposure tests. Dig. Liver Dis. 2014, 46, 264-269
130. National Institutes of Health (NIH) and LiverTox: Drug record. Ba Jiao Lian (Dysosma pleianthum). Last updated 19 May 2014. Available online: http://livertox.nih.gov/BaJiaoLian.htm (accessed on 15 March 2016).
131. Naser, B.; Schnitker, J.; Minkin, M.J.; de Arriba, S.G.; Nolte, K.U.; Osmers, R. Hepatotoxicity suspected by black cohosh: No evidence by metaanalysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause 2011, 18, 366-375
132. Teschke, R.; Schulze, J.; Schwarzenboeck, A.; Eickhoff, A.; Frenzel, C. Herbal hepatotoxicity: Suspected cases assessed for alternative causes. Eur. J. Gastroenterol. Hepatol. 2013, 25, 1093-1098
133. Teschke, R.; Frenzel, C.; Wolff, A.; Eickhoff, A.; Schulze, J. Drug induced liver injury: Accuracy of diagnosis in published reports. Ann. Hepatol. 2014, 13, 248-255
134. Navarro, V.J.; Barnhart, H.; Bonkovsky, H.L.; Davern, T.; Fontana, R.J.; Grant, L.; Reddy, K.R.; Seeff, L.B.; Serrano, J.; Averell, H.; et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014, 60, 1399-1408
135. Teschke, R.; Glass, X.; Schulze, J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports. Regul. Toxicol. Pharmacol. 2011, 61, 282-291
136. Haller, C.A.; Dyer, J.E.; Ko, R.; Olson, K.R. Making a diagnosis of herbal-related toxic hepatitis. West J. Med. 2002, 176, 39-44
137. Estes, J.D.; Stolpman, D.; Olyaei, A.; Corless, C.L.; Ham, J.M.; Schwartz, J.M.; Orloff, S. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 2003, 138, 852-858
138. Talari, P.; Talari, G.; Gundareddy, V.; Vemula, P.; Barmecha, J. Acute Hepatitis Associated with the Chinese Herbal Product bai shi wan. Available online: http://www.toothpicks.info/rc2/posters/2010/Internal_Medicine/Talari_P_Acute_hepatitis_associated.pdf (accessed on 15 March 2016).
139. Perharic-Walton, L.; Murray, V. Toxicity of Chinese herbal remedies. Lancet 1992, 340, 674
140. Kane, J.A.; Kane, S.P.; Jain, S. Hepatitis induced by traditional Chinese herbs: Possible toxic components. Gut 1995, 36, 146-147
141. Vautier, G.; Spiller, R.C. Safety of complementary medicines should be monitored. BMJ 1995, 311, 633
142. Yuen, M.F.; Tam, S.; Fung, J.; Wong, D.K.H.; Wong, B.C.Y.; Lai, C.L. Traditional Chinese Medicine causing hepatotoxicity in patients with chronic hepatitis B infection: A 1-year prospective study. Aliment. Pharmacol. Ther. 2006, 24, 1179-1186
143. Kang, S.H.; Kim, J.I.; Jeong, K.H.; Ko, K.H.; Ko, P.G.; Hwang, S.W.; Kim, E.M.; Kim, S.H.; Lee, H.Y.; Lee, B.S. Clinical characteristics of 159 cases of acute toxic hepatitis. Korean J. Hepatol. 2008, 14, 483-492, (abstract in English, article in Korean)
144. Sohn, C.H.; Cha, M.I.; Oh, B.J.; Yeo, W.H.; Lee, J.H.; Kim, W.; Lim, K.S. Liver transplantation for acute toxic hepatitis due to herbal medicines and preparations. J. Korean Soc. Clin. Toxicol. 2008, 6, 110-116, (abstract in English, article in Korean).
145. Cortez, E.; Boulger, C.; Bernard, A. Ban Tu Wan hepatotoxicity. BMJ Case Rep. 2012
146. Sangsuwan, C.; Udompanthurak, S.; Vannasaeng, S.; Thamlikitkul, V. Randomized controlled trial of Tinospora crispa for additional therapy in patients with type 2 diabetes mellitus. J. Med. Assoc. Thai. 2004, 87, 543-546, (abstract in English, article in Thai)
147. Motoyama, H.; Enomoto, M.; Yasuda, T.; Fujii, H.; Kobayashi, S.; Iwai, S.; Morikawa, H.; Takeda, T.; Tamori, A.; Sakaguchi, H.; et al. Drug-induced liver injury caused by a herbal medicine, bofu-tsu-sho-san. Nihon Shokakibyo Gakkai Zasshi 2008, 105, 1234-1239, (abstract in English, article in Japanese)
148. Hwang, S.H.; Park, J.A.; Jang, Y.S.; Lee, K.M.; Lee, D.S.; Ahn, B.M.; Lee, E.H. Case of acute cholestatic hepatitis caused by the seeds of Psoralea-corylifolia. Korean J. Hepatol. 2001, 7, 341-344, (abstract in English, article in Korean).
149. Nam, S.W.; Baek, J.T.; Lee, D.S.; Kang, S.B.; Ahn, B.M.; Chung, K.W. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin. Toxicol. 2005, 43, 589-591
150. Cheung, W.I.; Tse, M.L.; Ngan, T.; Lin, J.; Lee, W.K.; Poon, W.T.; Mak, T.W.; Leung, V.K.S.; Chau, T.N. Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related propriety medicine. Clin. Toxicol. 2009, 47, 683-685
151. Chau, T.N. Drug-induced liver injury: An update. Hong Kong Med. Diary 2008, 13, 23-26.
152. Lin, T.J.; Tsai, M.S.; Chiou, N.M.; Deng, J.F.; Chiu, N.Y. Hepatotoxicity caused by Breynia officinalis. Vet. Hum. Toxicol. 2002, 44, 87-88
153. Lin, T.J.; Su, C.C.; Lan, C.K.; Jiang, D.D.; Tsai, J.L.; Tsai, M.S. Acute poisonings with Breynia officinalis-An outbreak of hepatotoxicity. J. Toxicol. Clin. Toxicol. 2003, 41, 591-594
154. Yoshida, E.M.; McLean, C.A.; Cheng, E.S.; Blanc, P.D.; Somberg, K.A.; Ferrell, L.D.; Lake, J.R. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am. J. Gastroenterol. 1996, 91, 2647-2648
155. Kamiyama, T.; Nouchi, T.; Kojima, S.; Murata, N.; Ikeda, T.; Sato, C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am. J. Gastroenterol. 1997, 92, 703-704
156. Björnsson, E.S.; Bergmann, O.M.; Björnsson, H.K.; Kvaran, R.B.; Olafsson, S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013, 144, 1419-1425
157. Verucchi, G.; Calza, L.; Attard, L.; Chiodo, F. Acute hepatitis induced by traditional Chinese herbs used in the treatment of psoriasis. J. Gastroenterol. Hepatol. 2002, 17, 1342-1343
158. Kim, S.Y.; Yim, H.J.; Ahn, J.H.; Kim, J.H.; Kim, J.N.; Yoon, I.; Kim, D.I.; Lee, H.S.; Lee, S.W.; Choi, J.H. Two cases of toxic hepatitis caused by arrowroot juice. Korean J. Hepatol. 2009, 15, 504-509, (abstract in English, article in Korean)
159. Bae, S.H.; Kim, D.H.; Bae, Y.S.; Lee, K.J.; Kim, D.W.; Yoon, J.B.; Hong, J.H.; Kim, S.H. Toxic hepatitis associated with Polygoni multiflori. Korean J. Hepatol. 2010, 16, 182-186, (abstract in English, article in Korean)
160. Gono, Y.; Odaguchi, H.; Hayasaki, T.; Suzuki, K.; Oikawa, T.; Muranushi, A.; Akahoshi, T.; Hanawa, T. Clinical analysis of cases with drug-induced liver injury for Kampo medicine. Kampo Med. 2010, 61, 828-833, (abstract in English, article in Japanese)
161. Linnebur, S.A.; Rapacchietta, O.C.; Vejar, M. Hepatotoxicity associated with Chinese skullcap contained in Move Free Advanced dietary supplement: Two case reports and review of the literature. Pharmacotherapy 2010, 750, 258e-262e
162. Yang, L.; Aronsohn, A.; Hart, J.; Jensen, D. Herbal hepatotoxicity from Chinese skullcap: A case report. World J. Hepatol. 2012, 4, 231-233
163. Dhanasekaran, R.; Owens, V.; Sanchez, W. Chinese skullcap in Move Free arthritis supplement causes drug induced liver injury and pulmonary infiltrates. Case Rep. Hepatol. 2013, 965092
164. Kang, H.S.; Choi, H.S.; Yun, T.J.; Lee, K.G.; Seo, Y.S.; Yeon, J.E.; Byun, K.S.; Um, S.H.; Kim, C.D.; Ryu, H.S. A case of acute cholestatic hepatitis induced by Corydalis speciosa Max. Korean J. Hepatol. 2009, 15, 517-523. (In Korean)
165. Kim, Y.J.; Ryu, S.L.; Shim, J.W.; Kim, D.S.; Shim, J.Y.; Park, M.S.; Jung, H.L. A pediatric case of toxic hepatitis induced by Hovenia dulcis. Pediatr. Gastroenterol. Hepatol. Nutr. 2012, 15, 111-116
166. Woolf, G.M.; Petrovic, L.M.; Rojter, S.E.; Wainwright, S.; Villamil, F.G.; Katkov, W.N.; Michieletti, P.; Wanless, I.R.; Stermitz, F.R.; Beck, J.J.; et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann. Intern. Med. 1994, 121, 729-735
167. Horowitz, R.S.; Feldhaus, K.; Dart, R.C.; Stermitz, F.R.; Beck, J.J. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern. Med. 1996, 156, 899-903
168. Picciotti, A.; Campo, N.; Brizzolara, R.; Giusto, R.; Guido, G.; Sinelli, N.; Lapertosa, G.; Celle, G. Chronic hepatitis induced by Jin Bu Huan. J. Hepatol. 1998, 28, 165-167
169. Divinsky, M. Case report: Jin Bu Huan-Not so benign herbal medicine. Can Fam. Phys. 2002, 48, 1640-1642.
170. Inoue, H.; Yamazaki, S.; Shimizu, M.; Uozki, H.; Goto, T.; Ohnishi, S.; Koike, K. Liver injury induced by the Japanese herbal drug kamishoyosan. Gastroenterol. Hepatol. 2011, 7, 692-695.
171. Garcia-Moran, S.; Saez-Royuela, F.; Gento, E.; Lopez Morante, A.; Arias, L. Acute hepatitis associated with Camellia tea and Orthosiphon stamineus ingestion. Gastroenterol. Hepatol. 2004, 27, 559-560
172. Peyrin-Biroulet, L.; Petitpain, N.; Kalt, P.; Ancel, D.; Petit-Laurent, F.; Trechot, P.; Barraud, H.; Bronowicki, J.P. Probable hepatotoxicity from epigallocatecol gallate used for Phytotherapy. Gastroenterol. Clin. Biol. 2004, 28, 404-406. (In French)
173. Gloro, R.; Hourmand-Ollivier, I.; Mosquet, B.; Mosquet, L.; Rousselot, P.; Salamé, E.; Piquet, M.A.; Dao, T. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur. J. Gastroenterol. Hepatol. 2005, 17, 1135-1137
174. Javaid, A.; Bonkovsky, H.L. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): A growing concern. J. Hepatol. 2006, 45, 334-335
175. Jimenez-Saenz, M.; Martinez-Sanchez M del, C. Acute hepatitis associated with the use of green tea infusions. J. Hepatol. 2006, 44, 616-617
176. Bonkovsky, H.L. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann. Intern. Med. 2006, 144, 68-71
177. Molinari, M.; Watt, K.D.; Kruszyna, T.; Nelson, R.; Walsh, M.; Huang, W.Y.; Nashan, B.; Peltekian, K. Acute liver failure induced by green tea extracts: Case reports and review of the literature. Liver Transpl. 2006, 12, 1892-1895
178. Björnsson, E.; Olsson, R. Serious adverse liver reactions associated with herbal weight loss supplements. J. Hepatol. 2007, 47, 295-297
179. García-Cortés, M.; Borraz, Y.; Lucena, M.I.; Peláez, G.; Salmerón, J.; Diago, M.; Martínez-Sierra, M.C.; Navarro, J.M.; Planas, R.; Soria, M.J.; et al. Liver injury induced by “natural remedies”: An analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev. Esp. Enferm. Dig. 2008, 100, 688-695
180. Rohde, J.; Jacobsen, C.; Kromann-Andersen, H. Toxic hepatitis triggered by green tea. Ugeskr Laeger 2011, 173, 205-206, (abstract in English, article in Danish)
181. Nadir, A.; Agrawal, S.; King, P.D.; Marshall, J.B. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am. J. Gastroenterol. 1996, 91, 1436-1438
182. Borum, M.L. Fulminant exacerbation of autoimmune hepatitis after the use of Ma Huang. Am. J. Gastroenterol. 2001, 96, 1654-1655
183. Skoulidis, F.; Alexander, G.J.; Davies, S.E. Ma huang associated acute liver failure requiring liver transplantation. Eur. J. Gastroenterol. Hepatol. 2005, 17, 581-584
184. Reuben, A.; Koch, D.G.; Lee, W.M.; the Acute Liver Failure Study Group. Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study. Hepatology 2010, 52, 2065-2076
185. Aiba, T.; Takahashi, T.; Suzuki, K.; Okoshi, S.; Nomoto, M.; Uno, K.; Aoyagi, Y. Liver injury induced by a Japanese herbal medicine, sairei-to (TJ-114, Bupleurum and Hoelen combination, Chai-Ling-Tang). J. Gastroenterol. Hepatol. 2007, 22, 762-763
186. Tsuda, T.; Yashiro, S.; Gamo, Y.; Watanabe, K.; Hoshino, T.; Oikawa, T.; Hanawa, T. Discrepancy between clinical course and drug-induced lymphocyte stimulation tests in a case of saireito-induced liver injury accompanied by Sjögren syndrome. J. Altern. Complement. Med. 2010, 16, 501-505
187. Chen, M.Y.; Cai, J.T.; Du, Q. Hepatic veno-occlusive disease associated with the use of Gynura segetum. Eur. J. Intern. Med. 2007, 18, 609
188. Li, C.; Liang, X.S.; Li, C.Z. Sinusoidal obstruction syndrome associated with the ingestion of Gynura root. Clin. Toxicol. 2010, 48, 962-964
189. Cárdenas, A.; Restrepo, J.C.; Sierra, F.; Correa, G. Acute hepatitis due to shen-min: A herbal product derived from Polygonum multiflorum. J. Clin. Gastroenterol. 2006, 40, 629-632
190. But, P.P.H.; Tomlinson, B.; Lee, K.L. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet. Hum. Toxicol. 1996, 38, 280-282
191. Park, G.J.H.; Mann, S.P.; Ngu, M.C. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J. Gastroenterol. Hepatol. 2001, 16, 115-117
192. Battinelli, L.; Daniele, C.; Mazzanti, G.; Mastroianni, C.M.; Lichtner, M.; Coletta, S.; Costantini, S. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann. Intern. Med. 2004, 140, 587-588.
193. Panis, B.; Wong, D.R.; Hooymans, P.M.; De Smet, P.A.G.M.; Rosias, P.R. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J. Pediat. Gastroenterol. Nutr. 2005, 41, 256-258
194. Laird, A.R.; Ramchandani, N.; deGoma, E.M.; Avula, B.; Khan, I.A.; Gesundheit, N. Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome. Clin. Gastroenterol. 2008, 42, 861-862
195. Furukawa, M.; Kasajima, S.; Nakamura, Y.; Shouzushima, M.; Nagatani, N.; Takinishi, A.; Taguchi, A.; Fujita, M.; Niimi, A.; Misaka, R.; et al. Toxic hepatitis induced by Show-Wu-Pian, a Chinese herbal preparation. Intern. Med. 2010, 49, 1537-1540
196. Valente, G.; Sanges, M.; Campione, S.; Bellevicine, C.; de Franchis, G.; Sollazzo, R.; Matera, D.; Cimino, L.; Vecchione, R.; D’Arienzo, A. Herbal hepatotoxicity: A case of difficult interpretation. Eur. Rev. Med. Pharmacol. Sci. 2010, 14, 865-870
197. Jung, K.A.; Min, H.J.; Yoo, S.S.; Kim, H.J.; Choi, S.N.; Ha, C.Y.; Kim, H.J.; Kim, T.H.; Jung, W.T.; Lee, O.J.; et al. Drug-induced liver injury: Twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thun. Gut Liver 2011, 5, 493-499
198. Banarova, A.; Koller, T.; Payer, J. Toxic hepatitis induced by Polygonum multiflorum. Vnitr Lek 2012, 58, 958-962, (abstract in English, article in Slovak)
199. Cohen, S.M.; Heywood, E.; Pillai, A.; Ahn, J. Hepatotoxicity associated with the use of White Flood, a nutritional supplement. Pract. Gastroenterol. 2012, 10, 45-48.
200. Itoh, S.; Marutani, K.; Nishijima, T.; Matsuo, S.; Itabashi, M. Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang). Dig. Dis. Sci. 1995, 40, 1845-1848
201. Hsu, L.M.; Huang, Y.S.; Tsay, S.H.; Chang, F.Y.; Lee, S.D. Acute hepatitis induced by Chinese hepatoprotective herb xiao-chai-hu-tang. J. Chin. Med. Assoc. 2006, 69, 86-88
202. Rabe, C.; Musch, A.; Schirrmacher, P.; Kruis, W.; Hoffmann, R. Acute hepatitis induced by an aloe vera preparation: A case report. World J. Gastroenterol. 2005, 11, 303-304
203. Kanat, O.; Ozet, A.; Ataegin, S. Aloe vera-induced acute toxic hepatitis in a healthy young man. Eur. J. Intern. Med. 2006, 17, 589
204. Bottenberg, M.M.; Wall, G.C.; Harvey, R.L.; Habib, S. Oral Aloe vera-induced hepatitis. Ann. Pharmacother. 2007, 41, 1740-1743
205. Yang, H.N.; Kim, D.J.; Kim, Y.M.; Kim, B.H.; Sohn, K.M.; Choi, M.J.; Choi, Y.H. Aloe-induced toxic hepatitis. J. Korean Med. Sci. 2010, 25, 492-495
206. Smith, L.W.; Culvenor, C.C.J. Plant sources of hepatotoxic pyrrolizidine alkaloids. J. Nat. Prod. 1981, 44, 129-152
207. Nadir, A.; Reddy, D.; van Thiel, D.H. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: Case report and review of herbal hepatotoxicity. Am. J. Gastroenterol. 2000, 95, 3634-3637
208. Katz, M.; Saibil, F. Herbal hepatitis: Subacute hepatic necrosis secondary to chaparral leaf. J. Clin. Gastroenterol. 1990, 12, 203-206
209. Centers of Disease Control and Prevention. Chaparral-induced toxic hepatitis California and Texas 1992. J. Am. Med. Ass. 1992, 268, 3295-3298.
210. Smith, B.C.; Desmond, P.V. Acute hepatitis induced by the ingestion of the herbal medication chaparral. Aust. N. Z. J. Med. 1993, 23, 526
211. Alderman, S.; Goldfarb, S.; Malone, D.G. Cholestatic hepatitis after ingestion of chaparral leaf: Confirmation by endoscopic retrograde cholangio-pancreatography and liver biopsy. J. Clin. Gastroenterol. 1994, 19, 242-247
212. Batchelor, W.B.; Heathcote, J.; Wanless, I.R. Chaparral-induced hepatic injury. Am. J. Gastroenterol. 1995, 90, 831-833
213. Gordon, D.W.; Rosenthal, G.; Hart, J.; Sirota, S.; Baker, A.L. Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications. J. Am. Med. Assoc. 1995, 273, 489-490
214. Sheikh, N.M.; Philen, R.M.; Love, L.A. Chaparral-associated hepatotoxicity. Arch. Intern. Med. 1997, 157, 913-919
215. Ridker, P.M.; Ohkuma, S.; McDermott, W.V.; Trey, C.; Huxtable, R.J. Hepatic venoocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985, 88, 1050-1054
216. Weston, C.F.M.; Cooper, B.T.; Davies, J.D.; Levine, D.F. Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br. Med. J. 1987, 295, 183
217. Bach, N.; Thung, S.N.; Schaffner, F. Comfrey herb tea-induced hepatic veno-occlusive disease. Am. J. Med. 1989, 87, 97-99
218. Ridker, P.M.; McDermott, W.V. Comfrey herbs tea and hepatic veno-occlusive disease. Lancet 1989, 333, 657-658
219. Miskelly, F.G.; Goodyer, L.I. Hepatic and pulmonary complications of herbal medicine (letter). Postgrad Med. J. 1992, 68, 935
220. Georgia, M. Hepatotoxicity due to Atractylis gummifera. Clin. Toxicol. 1988, 26, 487-493
221. McDonnell, W.M.; Bhattacharya, R.; Halldorson, J.B. Fulminant hepatic failure after use of the herbal weight-loss supplement Exilis. Ann. Intern. Med. 2009, 151, 673-674
222. Mostefa-Kara, N.; Pauwels, A.; Pines, E.; Biour, M.; Levy, V.G. Fatal hepatitis after herbal tea (letter). Lancet 1992, 340, 674
223. Dao, T.; Peytier, A.; Galateau, F.; Valla, A. Chronic hepatitis due to germander. Gastroenterol. Clin. Biol. 1993, 17, 614-615.
224. Mattéi, A.; Rucay, P.; Samuel, D.; Feray, C.; Michel, R.; Bismuth, H. Liver transplantation for acute liver failure after herbal medicine (Teucrium polium) administration (letter). J. Hepatol. 1995, 22, 597
225. Laliberté, L.; Villeneuve, J.P. Hepatitis after the use of germander, a herbal remedy. Can. Med. Assoc. J. 1996, 154, 1689-1692.
226. Starakis, I.; Siagris, D.; Leonidou, L.; Mazakopakis, E.; Tsamandas, A.; Karatza, C. Hepatitis caused by the herbal remedyTeucrium polium L. Eur. J. Gastroenterol. Hepatol. 2006, 18, 681-683
227. Strahl, S.; Ehret, V.; Dahm, H.H.; Maier, K.P. Necrotising hepatitis after taking herbal remedies. Dtsch Med. Wschr. 1998, 123, 1410-1414. (In German)
228. Greving, I.; Meister, V.; Monnerjahn, C.; Müller, K.M.; May, B. Chelidonium majus: A rare reason for severe hepatotoxic reaction. Pharmacoepidemiol. Drug Saf. 1998, 7, S66-S69
229. Benninger, J.; Schneider, H.T.; Schuppan, D.; Kirchner, T.; Hahn, E.G. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Gastroenterology 1999, 117, 1234-1237
230. Crijns, A.P.; de Smet, P.A.; van den Heuvel, M.; Schot, B.W.; Haagsma, E.B. Acute hepatitis after use of herbal preparation with greater celandine (Chelidonium majus). Ned. Tijdschr. Geneeskd 2002, 146, 124-128. (In Dutch)
231. Hardeman, E.; van Overbeke, L.; Ilegems, S.; Ferrante, M. Acute hepatitis induced by greater celandine (Chelidonium majus). Acta Gastroenterol. Belg. 2003, 71, 281-282.
232. Stickel, F.; Pöschl, G.; Seitz, K.H.; Waldherr, R.; Hahn, E.G.; Schuppan, D. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand. J. Gastroenterol. 2003, 38, 565-568
233. Rifai, K.; Flemming, P.; Manns, M.P.; Trautwein, C. Severe drug hepatitis caused by Chelidonium majus. Internist 2006, 47, 749-751. (In German)
234. Conti, E.; De Checchi, G.; Mencarelli, R.; Pinato, S.; Rovere, P. Lycopodium similiaplex-induced acute hepatitis: A case report. Eur. J. Gastroenterol. Hepatol. 2008, 20, 469-471
235. Moro, P.A.; Cassetti, F.; Giugliano, G.; Falce, M.T.; Mazzanti, G.; Menniti-Ippolito, F.; Raschetti, R.; Santuccio, C. Hepatitis from Greater celandine (Chelidonium majus L.): Review of literature and report of a new case. J. Ethnopharmacol. 2009, 124, 328-332
236. Tarantino, G.; Di Minno, M.N.D.; Pezullo, M.G.; Pezzullo, L.S.; Milone, F.; Milone, M.; Capone, D. Drug-induced liver injury due to “natural products” used for weight loss: A case report. World J. Gastroenterol. 2009, 15, 2414-2417
237. European Medicines Agency (EMA). Assessment report on Chelidonium majus L., herba. Draft. 25 November 2010. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2011/01/WC500100940.pdf (accessed on 15 March 2016).
238. Duenas Sadornil, C.; Fabregas Piugtio, S.; Durandez, R. Hepatotoxicity due to Camelia sinensis. Med. Clin. 2004, 122, 677-678. (In Spanish)
239. Abu el Wafa, Y.; Benaventa Fernandez, A.; Talavera Fabuel, A.; Perez Ramos, M.A.; Ramos-Clemente, J.I. Acute hepatitis induced by Camellia sinensis (green tea). An. Med. Interna 2005, 22, 298. (In Spanish)
240. Martinez-Sierra, C.; Rendon Unceta, P.; Martin Herrera, L. Acute hepatitis after green tea ingestion. Med. Clin. 2006, 127, 119
241. Federico, A.; Tiso, A.; Loguercio, C. A case of hepatotoxicity caused by green tea. Free Radic. Biol. Med. 2007, 43, 474
242. Verheist, X.; Burvenich, P.; Van Sassenbroeck, D.; Gabiel, C.; Lootens, M.; Baert, D. Acute hepatitis after treatment for hair loss with oral green tea extracts (Camellia sinensis). Acta Gastroenterol. Belg. 2009, 72, 262-264.
243. Stillman, A.S.; Huxtable, R.; Consroe, P.; Kohnen, P.; Smith, S. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology 1977, 73, 349-352
244. Fox, D.W.; Hart, M.C.; Bergeson, P.S.; Jarrett, P.B.; Stillman, A.E.; Huxtable, R.J. Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J. Pediatr. 1978, 93, 980-982
245. Dara, L.; Hewett, J.; Lim, J.K. Hydroxycut hepatotoxicity: A case series and review of liver toxicity from herbal weight loss supplements. World J. Gastroenterol. 2008, 14, 6999-7004
246. Hoffmann, M.; Marbet, U.A.; Hurni, A.; Bianchi, L.; Göldi, H. Rezidiv einer medikamentös-toxischen Hepatitis. Schweiz Med. Forum 2005, 5, 147-148.
247. Duque, J.M.; Ferreiro, J.; Salgueiro, E.; Manso, G. Hepatotoxicity associated with the consumption of herbal slimming products. Med. Clin. 2007, 128, 238-239.
248. Elinav, E.; Pinsker, G.; Safadi, R.; Pappo, O.; Bromberg, M.; Anis, E.; Keinan-Boker, L.; Broide, E.; Ackerman, Z.; Nitzan Kaluski, D.; et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J. Hepatol. 2007, 47, 514-520
249. Schoepfer, A.M.; Engel, A.; Fattinger, K.; Marbet, U.A.; Criblez, D.; Reichen, J.; Zimmermann, A.; Oneta, C.M. Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J. Hepatol. 2007, 47, 521-526
250. Chao, S.; Anders, M.; Turbay, M.; Olaiz, E.; Mc Cormack, L.; Mastai, R. Toxic hepatitis by consumption of Herbalife products: A case report. Acta Gastroenterol. Latinoam 2008, 38, 274-277
251. Manso, G.; López-Rivaz, L.; Duque, J.M.; Salgueiro, E. Spanish reports of hepatotoxicity associated with Herbalife. J. Hepatol. 2008, 49, 289-290. Author reply 290-292
252. Stickel, F.; Droz, S.; Patsenker, E.; Bögli-Stuber, K.; Aebi, B.; Leib, S.L. Severe hepatotoxicity following ingestion of Herbalife nutritionally supplements contaminated with Bacillus subtilis. J. Hepatol. 2009, 50, 111-117
253. Jóhannsson, M.; Ormarsdóttir, S.; Olafsson, S. Hepatotoxicity associated with the use of Herbalife. Laeknabladid 2010, 96, 167-172
254. Chen, G.C.; Ramanathan, V.S.; Law, D.; Funchain, P.; Chen, G.C.; French, S.; Shlopov, B.; Eysselein, V.; Chung, D.; Reicher, S.; et al. Acute liver injury induced by weight-loss herbal supplements. World J. Hepatol. 2010, 2, 410-415
255. Appelhans, K.; Smith, C.; Bejar, E.; Henig, Y.S. Revisiting acute liver injury associated with Herbalife products. World J. Hepatol. 2011, 3, 275-277
256. Manso, G.; López-Rivas, L.; Salgueiro, M.E.; Duque, J.M.; Jimeno, F.J.; Andrade, R.J.; Lucena, M.I. Continuous reporting of new cases in Spain supports the relationship between Herbalife products and liver injury. Pharmacoepidemiol. Drug Saf. 2011, 20, 1080-1087
257. Appelhans, K.; Frankos, V.; Shao, A. Misconceptions regarding association between Herbalife products and liver related case reports in Spain. Pharmacoepidemiol. Drug Saf. 2012, 21, 333-334
258. Stevens, T.; Qadri, A.; Zein, N.N. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann. Intern. Med. 2005, 14, 477-478
259. Jones, F.J.; Andrews, A.H. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am. J. Gastroenterol. 2007, 102, 2357-2358
260. Shim, M.; Saab, S. Severe hepatotoxicity due to Hydroxycut: A case report. Dig. Dis. Sci. 2009, 54, 406-408
261. Fong, T.L.; Klontz, K.C.; Canas-Coto, A.; Casper, S.J.; Durazo, F.A.; Davern, T.J.; Hayashi, P.; Lee, W.M.; Seeff, L.B. Hepatotoxicity due to Hydroxycut: A case series. Am. J. Gastroenterol. 2010, 105, 1561-1566
262. Wainwright, J.; Schonland, M.M. Toxic hepatitis in black patients in Natal. S. Afr. Med. J. 1977, 51, 571-573
263. Wainwright, J.; Schonland, M.M.; Candy, H.A. Toxicity of Callilepis laureola. S. Afr. Med. J. 1977, 52, 313-315
264. Popat, A.; Shear, N.H.; Malkiewicz, I.; Stewart, M.J.; Steenkamp, V.; Thomson, S.; Neuman, M.G. The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin. Biochem. 2001, 34, 229-236
265. Fraquelli, M.; Colli, A.; Cocciolo, M.; Conte, D. Adult syncytial giant cell chronic hepatitis due to herbal remedy. J. Hepatol. 2000, 33, 505-508
266. Brauer, R.B.; Pfab, R.; Becker, K.; Berger, H.; Stangl, M. Fulminantes Leberversagen nach Einnahme des pflanzlichen Heilmittels Kava-Kava. Z Gastroenterol. 2001, 39, 30, (abstract in German).
267. Escher, M.; Desmeules, J.; Giostra, E.; Mentha, G. Hepatitis associated with kava, a herbal remedy for anxiety. Br. Med. J. 2001, 322, 139
268. Kraft, M.; Spahn, T.W.; Menzel, J.; Senninger, N.; Dietl, K.H.; Herbst, H.; Domschke, W.; Lerch, M.M. Fulminant liver failure after administration of the herbal antidepressant Kava-Kava. Dtsch Med. Wschr. 2001, 126, 970-972. (In German)
269. Russmann, S.; Lauterburg, B.H.; Helbling, A. Kava hepatotoxicity. Ann. Intern. Med. 2001, 135, 68-69
270. Saß, M.; Schnabel, S.; Kröger, J.; Liebe, S.; Schareck, W.D. Akutes Leberversagen durch Kava Kava-eine seltene Indikation zur Lebertransplantation. Z. Gastroenterol. 2001, 39, 29. (In German)
271. Bujanda, L.; Palacios, A.; Silvariño, R.; Sánchez, A.; Muñoz, C. Hepatitis aguda icterica secundaria a kava. Gastroenterol. Hepatol. 2002, 25, 434-435
272. Denham, A.; McIntyre, M.; Whitehouse, J. Kava-The unfolding story: Report on a work-in-progress. J. Altern. Complement. Med. 2002, 8, 237-263
273. Weise, B.; Wiese, M.; Plötner, A.; Ruf, B.R. Toxic hepatitis after intake of kava-kava. Verdauungskrankheiten 2002, 4, 166-169. (In German)
274. Gow, P.J.; Connelly, N.J.; Hill, R.L.; Crowley, P.; Angus, P.W. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med. J. Aust. 2003, 178, 442-443
275. Humberston, C.L.; Akhtar, J.; Krenzelok, E.P. Acute hepatitis induced by kava kava. J. Toxicol. Clin. Toxicol. 2003, 41, 109-113
276. Russmann, S.; Barguil, Y.; Cabalion, P.; Kritsanida, M.; Duhet, D.; Lauterburg, B.H. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur. J. Gastroenterol. Hepatol. 2003, 15, 1033-1036
277. Schulze, J.; Raasch, W.; Siegers, C.P. Toxicity of kava pyrones, drug safety and precautions-A case study. Phytomedicine 2003, 10, 68-73
278. Stickel, F.; Baumüller, H.M.; Seitz, K.; Vasilakis, D.; Seitz, G.; Seitz, H.K.; Schuppan, D. Hepatitis induced by kava (Piper methysticum rhizoma). J. Hepatol. 2003, 39, 62-67
279. Christl, S.U.; Seifert, A. Seeler D: Toxic hepatitis after consumption of traditional kava preparation. Int. Soc. Travel. Med. 2009, 16, 55-56
280. McGee, J.; Patrick, R.S.; Wood, C.B.; Blumgart, L.H. A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption. J. Clin. Pathol. 1976, 29, 788-794
281. Harvey, J.; Colin-Jones, D.G. Mistletoe hepatitis. Br. Med. J. 1981, 282, 186-187
282. Hyde, F.F. Mistletoe hepatitis. Br. Med. J. 1981, 282, 739
283. Colin-Jones, D.G.; Harvey, J. Mistletoe hepatitis. Br. Med. J. 1982, 284, 744-745
284. Farnsworth, N.R.; Loub, W.D. Mistletoe hepatitis. Br. Med. J. 1981, 283, 1058
285. Stirpe, F. Mistletoe hepatitis. Br. Med. J. 1983, 1, 29.
286. Millonig, G.; Stadlmann, S.; Vogel, W. Herbal hepatotoxicity: Acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur. J. Gastroenterol. Hepatol. 2005, 17, 445-447
287. Stadlbauer, V.; Fickert, P.; Lackner, C.; Schmerlaib, J.; Krisper, P.; Trauner, M.; Stauber, R.E. Hepatotoxicity of NONI juice: Report of two cases. World J. Gastroenterol. 2005, 11, 4758-4760
288. Yüce, B.; Gülberg, V.; Diebold, J.; Gerbes, A.L. Hepatitis induced by Noni juice from Morinda citrifolia: A rare cause of hepatotoxicity or the tip of a iceberg? Digestion 2006, 73, 167-170
289. López-Cepero Andrada, J.M.; Lerma Castilla, S.; Fernandèz Olvera, M.D.; Amaya Vidal, A. Hepatotoxicity caused by a Noni (Morinda citrifolia) preparation. Espanola de Patologia Digestiva 2007, 99, 179-181. (In Spanish)
290. Stadlbauer, V.; Weiss, S.; Payer, F.; Stauber, R.E. Herbal does not at all mean innocuous: The sixth case of hepatotoxicity associated with Morinda citrifolia (Noni). Am. J. Gastroenterol. 2008, 103, 2406-2407
291. Yu, E.L.; Sivagnanam, M.; Ellis, L.; Huang, J.S. Acute hepatotoxicity after ingestion of Morinda citrifolia (Noni Berry) juice in a 14-year-old boy. J. Pedriatr. Gastroenterol. Nutr. 2011, 52, 222-224
292. Altan, E.; Bitik, B.; Kalpkci, Y.; Dogan, E.; Altundag, K. Probable hepatotoxicity related to Nerium oleander extract in a patient with metastatic synovial sarcoma of the knee. J. Altern. Complement. Med. 2009, 15, 113
293. Mokhobo, K.P. Herb use and necrodegenerative hepatitis. S. Afr. Med. J. 1976, 50, 1096-1099
294. Vallance, W.B. Pennyroyal poisoning: A fatal case. Lancet 1955, 266, 850-851
295. Sullivan, J.B.; Rumack, B.H.; Thomas, H.; Peterson, R.G.; Bryson, P. Pennyroyal oil poisoning and hepatotoxicity. J. Am. Med. Assoc. 1979, 242, 2873-2874
296. Anderson, I.B.; Mullen, W.H.; Meeker, J.E.; Khojasteh-Bakht, S.C.; Oishi, S.; Nelson, S.D.; Blanc, P.D. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review o the literature. Ann. Intern. Med. 1996, 124, 726-734
297. Bakerink, J.A.; Gospe, S.M.; Dimand, R.J.; Eldridge, M.W. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 1996, 98, 944-947
298. Joshi, D.; Cross, T.J.S.; Wong, V.S. Acute drug induced hepatitis secondary to a weight loss product purchased over the internet. Nutr. J. 2007, 6
299. Roselle, H.; Ekatan, A.; Tzeng, J.; Sapienza, M.; Kocher, J. Symptomatic hepatitis associated with the use of herbal Red Yeast Rice. Ann. Intern. Med. 2008, 149, 516-517
300. Larrey, D. Hepatotoxicity of herbal remedies. J. Hepatol. 1997, 26, 47-51
301. Lapi, F.; Gallo, E.; Giocaliere, E.; Vietri, M.; Baronti, R.; Pieraccini, G.; Tafi, A.; Menniti-Ippolito, F.; Mugelli, A.; Firenzuoli, F.; et al. Acute liver damage due to Serenoa repens: A case report. Br. J. Clin. Pharmacol. 2010, 69, 558-560
302. MacGregor, F.B.; Abernethy, V.E.; Dahabra, S.; Cobden, I.; Hayes, P.C. Hepatotoxicity of herbal remedies. Br. Med. J. 1989, 299, 1156-1157
303. Caldwell, S.H.; Feeley, J.W.; Wieboldt, T.F.; Featherston, P.L.; Dickson, R.C. Acute hepatitis with use of over-the-counter herbal remedies. Va Med. Q. 1994, 121, 31-33
304. Hullar, T.E.; Sapers, B.L.; Ridker, P.M.; Judkins, R.L.; Huth, T.S.; Farraye, F.A. Herbal toxicity and fatal hepatic failure (letter). Am. J. Med. 1999, 106, 267-268
305. Beuers, U.; Spengler, U.; Pape, G.R. Hepatitis after chronic abuse of senna. Lancet 1991, 337, 372-373
306. Seybold, U.; Landauer, L.; Hillebrand, S.; Goebel, F.D. Senna-induced hepatitis in a poor metabolizer. Ann. Intern. Med. 2004, 141, 650-651
307. Vanderperren, B.; Rizzo, M.; Angenot, L.; Haufroid, V.; Jadoul, M.; Hantson, P. Acute liver failure with renal impairment related to the abuse of Senna anthraquinone glycosides. Ann. Pharmacother. 2005, 39, 1353-1357
308. Mennecier, D.; Saloum, T.; Dourthe, P.M.; Bronstein, J.A.; Thiolet, C.; Farret, O. Acute hepatitis after phytotherapy. Présse Med. 1999, 28, 966
309. De Smet, P.A.G.M.; van den Eertwegh, A.J.M.; Lesterhuis, W.; Stricker, B.H.C. Hepatotoxicity associated with herbal tablets. BMJ 1996, 313, 92
310. Takegoshi, K.; Tohyama, T.; Okuda, K.; Suzuki, K.; Ohta, G. A case of Venoplant-induced hepatic injury. Gastroenterol. Jpn. 1986, 21, 62-65
311. Mathieu, N.; Bouallegue, L.; Mognol, P.; Vallot, T.; Soule, J.C. Hepatic toxicity probably due to X-elles in phytotherapy. Gastroenterol. Clin. Biol. 2005, 29, 1188-1189
312. Hayashi, P.H.; Fontana, R.J.; Chalasani, N.P.; Stolz, A.A.; Talwalkar, J.A.; Navarro, V.J.; Lee, W.M.; Davern, T.J.; Kleiner, D.E.; Gu, J.; et al. Under-reporting of poor adherence to monitoring guidelines for severe cases of Isoniazid hepatotoxicity. Clin. Gastroenterol. Hepatol. 2015, 13, 1676-1682
313. Chalasani, N.P.; Hayashi, P.H.; Bonkovsky, H.L.; Navarro, V.J.; Lee, W.M.; Fontana, R.J. ACG Clinical guideline: The diagnosis and management of idiosyncratic drug-induced liver injury. Am. J. Gastroenterol. 2014, 109, 950-966
314. Mohabbat, O.; Younos, M.S.; Merzad, A.A.; Srivastava, R.N.; Sediq, G.G.; Aram, G.N. An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet 1976, 308, 269-271
315. Kakar, F.; Akbarian, Z.; Leslie, T.; Mustafa, M.L.; Watson, J.; van Egmond, H.P.; Omar, M.F.; Mofleh, J. An outbreak of hepatic veno-occlusive disease in western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J. Toxicol. 2010, 313280
316. Tandon, R.K.; Tandon, B.N.; Tandon, H.D. Study of an epidemic of venoocclusive disease in India. Gut 1976, 17, 849-855
317. Tandon, B.N.; Tandon, H.D.; Tandon, R.K.; Narndranathan, M.; Joshi, Y.K. An epidemic of veno-occlusive disease of the liver in central India. Lancet 1976, 308, 271-272